HuMAB companies Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : HuMAB companies

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Icebrg who wrote (544)	6/19/2003 4:13:18 PM
From: Gary Mohilner	of 1022

Erik, I believe you're aware that in the past IMGN's CEO has been rather dismissive of SGEN's linker as well. IMGN's linker has proven safe and is currently involved in four different drug trials. SGEN's linker, which their future is based on, I do not believe is yet in clinical trials. SGEN's earlier linker is thought to be wanting. I'm certainly not putting down SGEN's technology, just pointing out that it remains to be proven. IMGN's linker may certainly be improved upon in the future, but as I understand it, the emphasis has been placed on improved effector molecules, which could also be the key to curing some diseases that DM1 won't. The reality is, it's awfully early to judge the capabilities of both of these technologies. Both have the potential of being very successful in the future, time will tell. Gary

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next